![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Mölken Maureen P.M.H. Rutten-van
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.25, Iss.8, 2007-01, pp. : 695-711
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Roflumilast: In Chronic Obstructive Pulmonary Disease
By Sanford Mark
Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Lock Kevin Wilson Koo Murphy Daniel Riesco Juan Antonio
Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 17, 2011-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Mölken Maureen P.M.H. Rutten-van Goossens Lucas M.A.
PharmacoEconomics, Vol. 30, Iss. 4, 2012-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Roflumilast: a guide to its use in chronic obstructive pulmonary disease
Drugs & Therapy Perspectives, Vol. 27, Iss. 9, 2011-09 ,pp. :